• Users Online: 415
  • Print this page
  • Email this page

  Article Access Statistics

Year : 2019 | Volume:  2 | Issue Number:  4 | Page:  167-173

ORIGINAL ARTICLE

Phase 2 clinical trial of VAL-083 as first-line treatment in newly-diagnosed MGMT-unmethylated glioblastoma multiforme (GBM): Halfway report
Guo Chengcheng, Yang Qunying, Li Jiawei, Wu Shaoxiong, Deng Meiling, Du Xiaojing, Sai Ke, Jiang Xiaobing, Chen Zhenghe, Zhang Ji, Lin Fuhua, Wang Jian, Chen Yinsheng, Ke Chao, Zhang Xiangheng, Ju Xue, Mou Yonggao, Bacha Jeffrey, Steino Anne, Kanekal Sarath, Kwan Claire, Johnson Gregory, Schwartz Richard, Langlands John, Brown Dennis, Chen Zhong-ping

Number of times this article was viewed 4520
Number of times this article has been printed  from the site 149
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0
Back To Article